The impact of the severe financial crisis on drug persistence and disease course in IBD patients in Lebanon

被引:0
|
作者
Sharara, A. [1 ]
Ibrahim, M. A. [1 ]
Allam, J. [1 ]
Haidar-Ahmad, D. [2 ]
Chalhoub, C. [2 ]
Francis, R. [2 ]
机构
[1] Amer Univ Beirut, Gastroenterol & Hepatol, Beirut, Lebanon
[2] I Battle Dis Patient Assoc, Res, Beirut, Lebanon
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P855
引用
收藏
页码:979 / 979
页数:1
相关论文
共 50 条
  • [1] SEVERE IMPACT OF THE ECONOMIC CRISIS ON TREATMENT PERSISTENCE IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: A MULTICENTRIC CROSS-SECTIONAL STUDY IN LEBANON
    Asmar, S.
    Messaykeh, J.
    Hilal, N.
    Rida, M. A.
    Mroue, K.
    Aouad, K.
    Minkara, F.
    Hajjar, A.
    Ziade, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2030 - 2031
  • [2] HYPOVITAMINOSIS D CORRELATES WITH A MORE SEVERE DISEASE COURSE IN IBD PATIENTS
    Tapete, G.
    Almerigogna, V.
    Bucciero, F.
    Cozzi, A.
    Giannotta, M.
    Macri, G.
    Milani, S.
    Milla, M.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E174 - E174
  • [3] The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
    Mwinyi, Jessica
    Grete-Wenger, Christa
    Eloranta, Jyrki J.
    Kullak-Ublick, Gerd A.
    PPAR RESEARCH, 2012, 2012
  • [4] THE IMPACT OF PPARγ GENETIC VARIANTS ON IBD SUSCEPTIBILITY AND IBD DISEASE COURSE
    Mwinyi, J.
    Grete, C.
    Eloranta, J. J.
    Kullak-Ublick, G. A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 42 - 42
  • [5] Exploring the Impact of Political Patronage Networks on Financial Stability: Lebanon's 2019 Economic Crisis
    Abou Ltaif, Samar
    Mihai-Yiannaki, Simona
    ECONOMIES, 2024, 12 (07)
  • [6] COMBINATION THERAPY OF VEDOLIZUMAB AND A TNF ANTAGONIST IN IBD PATIENTS WITH SEVERE CHRONIC ACTIVE, THERAPY REFRACTORY DISEASE COURSE
    Kuehbacher, Tanja
    AbuHashem, Raed
    Langel, Natalie
    Schreiber, Stefan
    Drvarov, Oliver
    GASTROENTEROLOGY, 2017, 152 (05) : S398 - S398
  • [7] Combination therapy of vedolizumab and a TNF antagonist in IBD patients with severe chronic active, therapy refractory disease course
    Kuehbacher, T.
    Abu Hashem, R.
    Langel, N.
    Schreiber, S.
    Drvarov, O.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S357 - S357
  • [8] IBD PATIENTS WITH SEVERE DISEASE ARE AT GREATER RISK OF DEVELOPING PNEUMONIA PRIOR TO IBD DIAGNOSIS
    Gregory, Martin H.
    Ciorba, Matthew A.
    Wiitala, Wyndy L.
    Stidham, Ryan W.
    Higgins, Peter D.
    Hou, Jason K.
    Feagins, Linda A.
    Govani, Shail M.
    Waljee, Akbar K.
    GASTROENTEROLOGY, 2017, 152 (05) : S781 - S782
  • [9] The impact of financial crisis on coronary artery disease burden in Greece
    Sanidas, Elias A.
    Papaioannou, Theodoros G.
    Papadopoulos, Dimitrios P.
    Tatsi, Konstantina
    Velliou, Maria
    Dalianis, Nikolaos
    Paizis, Ioannis
    Anastasiadis, George
    Kelepesis, Glaukos
    Bonou, Maria
    Tsioufis, Kontantinos
    Barbetseas, John
    HELLENIC JOURNAL OF CARDIOLOGY, 2019, 60 (03) : 185 - 188
  • [10] Does Persistent Stress Impact Quality of Life and Disease Course in Patients With IBD? A 4 Year Prospective Study
    Rivers, Claudia Ramos
    Szigethy, Eva
    Baker, Kimberly
    Hashash, Jana G.
    Dunn, Michael A.
    Regueiro, Miguel
    Barrie, Arthur
    Schwartz, Marc
    Swoger, Jason M.
    Baidoo, Leonard
    Binion, David G.
    GASTROENTEROLOGY, 2015, 148 (04) : S39 - S39